Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

AZNs anselamimab fails to meet key goals in late-stage AL amyloidosis trials despite signs of subgroup benefit.…

AstraZeneca therapy for clearing protein deposits fails main goal in late-stage study…

AstraZeneca on Wednesday said that its experimental drug anselamimab did not meet the main goal of a late-stage study for…

ZÜRICH (dpa-AFX Analyser) - Die schweizerische Großbank UBS hat Astrazeneca auf "Buy" mit einem Kursziel von 14200 Pence belassen. In…

LONDON (dpa-AFX Broker) - Positive Studiendaten zu einem Medikament von Astrazeneca sind am Montag an der Londoner Börse gut…

Shares in AstraZeneca PLC (LSE:AZN) and GSK PLC (LSE:GSK, NYSE:GSK) were both down over 1% on Friday, but the shares are worth buying, analysts…

AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio.…

Der britische Pharmakonzern spreche derzeit mit Summit Therapeutics über eine Vereinbarung, in deren Rahmen AstraZeneca über mehrere Jahre bis zu…

Summit Therapeutics and AstraZeneca are discussing a partnership deal worth as much as $15 billion, Bloomberg News reported on Thursday,…

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Astrazeneca von 14524 auf 14806 Pence angehoben…

Suggestions that AstraZeneca might cross the Atlantic should act as a huge wake-up call.…

AstraZeneca is the most valuable company listed on London’s FTSE 100 index.…

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca…

Astrazeneca (AZN) reached $71.46 at the closing of the latest trading day, reflecting a +2.26% change compared to its last…

Trading in AstraZenecas (NASDAQ: AZN) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to…